Alosetron (Lotronex) is back: should I use it to treat my patients with irritable bowel syndrome?
Shen
Bo
B
Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation, OH 44195, USA.
Soffer
Edy E
EE
D002243:Carbolines / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000145:classification / Q000188:drug therapy*; D000075202:Contraindications; D003967:Diarrhea / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D010353:Patient Education as Topic
D002243:Carbolines; D005765:Gastrointestinal Agents; C090840:alosetron